ReproCELL Inc.(製薬・医療分野):企業M&A動向

◆英語タイトル:ReproCELL Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH218283D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月27日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

ReproCELL Inc. (ReproCELL) is a biotechnology company. The company develops and commercializes stem cell technologies. Its products include primate ES cell medium, human ES/iPS cell culture kit, reprostem, reprocoat, reproXF, reproFF2, reproFF, reprocardio 2 (frozen single cells), reprocardio assay medium (100mL), reprocardio coat for patch clamp, reprocardio culture medium 2 (80mL), ReproNeuro Glu kit and Alzheimer’s Disease Model Cells, reproneuro DA kit, reproneuro ach kit and alzheimer’s disease model cells, dopamine reuptake assay service, and assay service of GLP 1 or GIP primary cells. ReproCELL is headquartered in Yokohama, Kanagawa, Japan.

ReproCELL Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
ReproCELL Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
ReproCELL Inc., Medical Devices Deals, 2009 to YTD 2015 9
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 10
ReproCELL Inc., Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 12
Venture Financing 13
Reinnervate Raises US$2.30 Million In Venture Financing 13
Partnerships 14
ReproCELL Enters Into Distribution Agreement With Laboratorios Conda 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 16
Reinnervate Enters Into Co-Development Agreement With Kirkstall 17
ReproCELL Enters Into Co-Development Agreement With NIBIO 18
LGC Standards Enters Into Distribution Agreement With Reinnervate 19
Reinnervate Enters Into Co-Development Agreement With LGC Standards 20
BioServe Enters Into Strategic Alliance With The Windber Research Institute 21
BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School 22
BioServe Enters Into Co-Development Agreement With Protein Biotechnologies 23
BioServe Enters Into Co-Development Agreement With Fox Chase Cancer Center 24
Cellartis Enters Into Technology Integration Agreement With ReproCELL 25
Licensing Agreements 26
ReproCELL Enters Into Licensing Agreement With iPS Academia Japan 26
Equity Offering 27
ReproCELL Completes IPO For US$20.8 Million 27
Acquisition 28
ReproCELL Acquires BioServe Biotechnologies 28
ReproCELL Acquires Reinnervate 29
ReproCELL Inc. – Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
ReproCELL Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
ReproCELL Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
ReproCELL Inc., Deals By Therapy Area, 2009 to YTD 2015 8
ReproCELL Inc., Medical Devices Deals, 2009 to YTD 2015 9
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 10
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 12
Reinnervate Raises US$2.30 Million In Venture Financing 13
ReproCELL Enters Into Distribution Agreement With Laboratorios Conda 14
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 15
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 16
Reinnervate Enters Into Co-Development Agreement With Kirkstall 17
ReproCELL Enters Into Co-Development Agreement With NIBIO 18
LGC Standards Enters Into Distribution Agreement With Reinnervate 19
Reinnervate Enters Into Co-Development Agreement With LGC Standards 20
BioServe Enters Into Strategic Alliance With The Windber Research Institute 21
BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School 22
BioServe Enters Into Co-Development Agreement With Protein Biotechnologies 23
BioServe Enters Into Co-Development Agreement With Fox Chase Cancer Center 24
Cellartis Enters Into Technology Integration Agreement With ReproCELL 25
ReproCELL Enters Into Licensing Agreement With iPS Academia Japan 26
ReproCELL Completes IPO For US$20.8 Million 27
ReproCELL Acquires BioServe Biotechnologies 28
ReproCELL Acquires Reinnervate 29
ReproCELL Inc., Key Competitors 30
ReproCELL Inc., Key Employees 31
ReproCELL Inc., Other Locations 32
ReproCELL Inc., Subsidiaries 32

List of Figures
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
ReproCELL Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
ReproCELL Inc., Medical Devices Deals, 2009 to YTD 2015 9

★海外企業調査レポート[ReproCELL Inc.(製薬・医療分野):企業M&A動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Chemicals Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SK Chemicals Co., Ltd. Mergers …
  • GMR Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GMR Group Mergers and Acquisiti …
  • Goa Carbon Limited (GOACARBON):企業の財務及び戦略的SWOT分析
    Summary Goa Carbon Limited (Goa Carbon) is a petcoke calciner company that manufactures and markets calcined petroleum coke. The company offers calcined petroleum coke to aluminum smelters, graphite electrode and titanium dioxide manufacturers, and chemical and metallurgic industries. It has plants …
  • SafeNet Inc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SafeNet Inc Mergers and Acquisi …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Brammer Plc (BRAM):企業財務及び戦略的SWOT分析
    Summary Brammer Plc (Brammer), formerly Bubbleminster Limited is an MRO distribution company that offers industrial maintenance, repair and overhaul product distribution. The company offers products, which include bearings and seals, electrical power transmission products, mechanical power transmiss …
  • Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報
    Summary Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological an …
  • PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析
    SummaryPDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • TELUS Corporation:企業の戦略・SWOT・財務分析
    SummaryTELUS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Western Potash Corp.の企業概要及び財務/SWOT分析
    Western Potash Corp. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Western Potash Corp. annual and quarterly forecasts made by stock market experts. The report also enables …
  • Banco Comercial Portugues, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco Comercial Portugues, S.A. …
  • Rakuten Inc (4755):企業の財務・戦略的SWOT分析
    Rakuten Inc (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Royal BAM Group nv:企業の戦略・SWOT・財務分析
    SummaryRoyal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Marina Biotech, Inc. (formerly MDRNA, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Marina Biotech, Inc. (formerly …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務分析
    SummaryTempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • RuiYi Inc.(製薬・医療分野):企業M&A動向
    Summary RuiYi Inc. (RuiYi) is a pharmaceutical company. The company discovers and develops biologic therapeutics for healthcare market. Its products include RYI-008, RYI-018, Avatar, and Kirin. The company’s RYI-008 is a monoclonal antibody used in the treatment of rheumatoid arthritis. Its product …
  • HDR, Inc.:企業概要及び戦略的SWOT分析
    HDR, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Transeuro Energy Corp. (TSU.H)(石油・ガス分野):企業M&A動向
    Summary Transeuro Energy Corp. (Transeuro Energy) is an oil and gas exploration and development company. The company carries out acquisition, exploration, development, and production of crude oil, petroleum, condensate, and natural gas in Canada, Ukraine, and Jordan. It holds interest in the Beaver …
  • Almirall S.A.:企業の戦略・SWOT・財務分析
    SummaryAlmirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • ON Semiconductor Corp (ON):企業の財務・戦略的SWOT分析
    ON Semiconductor Corp (ON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆